Bombardier Inc. Doesn’t Want You to Know This

These three things are standing in the way of Bombardier Inc’s (TSX:BBD.B) viability.

| More on:

It has been one year since things began to fall apart over at Bombardier (TSX:BBD.B), following a series of delays with its prototype C Series aircrafts. Since then there have been thousands of layoffs, management shuffles, and a pummeling of Bombardier’s stock. In November, however, the stock managed to climb back up to $4.43 as tangible progress was made with the C Series.

All of that forward momentum then came to a sudden stop in January, and on Thursday a series of announcements were made that could either make or break the company. The burning question for investors is whether or not Bombardier can ever bring about a positive return.

Black Thursday

Bombardier’s Q4 results brought some unexpected surprises this year. First off, both CEO Pierre Beaudoin and Chairman Laurent Beaudoin announced that they would be taking a step down on the corporate ladder and would be appointing Alain Bellemare as the new CEO. This move has been made to show investors that the company is moving towards an era of change, while still maintaining the core of its current management team.

This is also to shift attention away from the now outgoing CEO’s tenure, which is marked by a 70% drop in stock price and numerous product delays which have dragged the company to the point it is today. Bombardier implemented a similar strategy to satiate investors earlier in the year when it split its aerospace division into three parts.

The next major announcement that came out was that Bombardier would be suspending its dividend in an effort to save cash. The company then followed up this unexpected revelation with a call to raise $1.5 billion in additional debt and $600 million in equity.

Death by stock price

Investors reacted swiftly to these announcements as the share price plummeted from $3.05 to $2.50. These announcements have only been the tip of the iceberg in what has been a terrible year over at Bombardier. Due to all the negative publicity, even any sort of good news gets unacknowledged. Bombardier did manage to post record revenues of $20.1 billion in 2014, up from $18.1 billion in 2013.

Death by delays

The largest millstone around the neck of Bombardier is its apparent inability to bring about new products on time and on budget. The C Series for example is $2 billion over budget and a year behind its original delivery date. Then you have Bombardier’s business aircraft division LearJet which despite finally becoming number one in terms of sales was forced to “pause” production of the Learjet 85 due to delays and lack of interest. This shutdown cost Bombardier $1.4 billion in write-downs and led to a year end net loss of $1.2 billion in 2014.

Death by debt

If we want to understand Bombardier we have to understand what its management is thinking and why it is acting the way it is. Management believes that they can succeed, but the company is quickly drowning in debt. In the year-end financials we see $7.3 billion in long term debt, $3 billion in interest payments, and $11 billion in purchase obligations. This is all above and beyond the $2.1 billion in additional debt and equity Bombardier just announced that it would be seeking. This debt may become more expensive now that Moody’s has cut its credit rating from B-a3 to B-1.

Despite all the overspending and delays, Bombardier believes that the C Series can still be a generational aircraft, and has the potential to erase all the bad memories of 2014 and 2015. The problem is that the C Series only has managed to secure 243 firm orders, which is still short of the 300 projected by management.

Let’s be frank, Bombardier has dug itself into a deep hole and its stock price is doing a good job of reflecting that. The delays and debt have shocked investors and Bombardier is attempting to pull out all the stops to keep them on board. The reality that Bombardier doesn’t want you to realize is that it could take up to five years to dig itself out of this hole.

Fool contributor Cameron Conway has no position in any stocks mentioned.

More on Investing

telehealth stocks
Dividend Stocks

2 High-Yield Dividend Stocks That Could Be a Safer Pick for Canadian Retirees

These two quality dividend stocks with solid underlying businesses, consistent dividend payouts, and visible growth prospects are ideal for retirees.

Read more »

data analyze research
Stocks for Beginners

3 Canadian Stocks to Buy Before the Next Earnings Surprise

Some earnings-season winners show up before the headlines, with strong momentum, clear catalysts, and room to beat expectations.

Read more »

Canada Day fireworks over two Adirondack chairs on the wooden dock in Ontario, Canada
Retirement

How This Bolder Savings Approach Could Help You Catch Up on Retirement Goals

Do not let uncertainties derail your retirement plans. Learn how to boost your savings for a secure retirement today.

Read more »

Stocks for Beginners

The Canadian ETFs That Deserve Far More Attention Than They’re Getting

These three Canadian ETFs aren't just being overlooked, they're some of the best funds you can buy in this environment.

Read more »

rising arrow with flames
Tech Stocks

1 Canadian Stock Supercharged to Surge in 2026

VitalHub crossed $100 million in revenue in 2025 and is building AI tools customers are already paying for. Here is…

Read more »

dividend stocks are a good way to earn passive income
Stocks for Beginners

5 Stocks to Hold for the Next Decade

Take a closer look at these TSX stocks if you’re looking to allocate some investment capital to Canadian equities for…

Read more »

cookies stack up for growing profit
Dividend Stocks

4 Dividend Stocks I’d Happily Double My Position in Today

These four quality dividend stocks offer attractive buying opportunities in this uncertain outlook.

Read more »

Woman checking her computer and holding coffee cup
Investing

2 TSX Stocks I’d Buy Aggressively the Next Time Markets Pull Back

Discover how the stock market is recovering from the Iran war. Analyze stock trends and the performance of Celestica stock.

Read more »